Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997 Oct;41(4):500-4.
doi: 10.1136/gut.41.4.500.

Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide

Affiliations
Clinical Trial

Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide

W Schwizer et al. Gut. 1997 Oct.

Abstract

Background: Exogenous cholecystokinin (CCK) inhibits antral motility and slows gastric emptying (GE) but the effect of endogenous CCK on the gastric motor mechanisms responsible for GE remains unclear.

Methods: The effect of the CCK-A antagonist loxiglumide (LOX) on GE and motility was studied using magnetic resonance imaging in six healthy volunteers after ingestion of 500 ml Intralipid 10% (550 kcal). Subjects were studied in the supine position on two occasions during intravenous infusion of LOX (66 mumol/kg/h for 10 min followed by 22 mumol/kg/h) or placebo. GE was determined every 15 minutes using transaxial abdominal scans and motility was studied by means of 120 coronal scans, 1.2 seconds apart. For each coronal image the proximal and distal (antral) diameters were measured at a fixed point in the stomach to determine contraction frequency (ACF) and amplitude (AMP).

Results: GE was faster during LOX infusion than placebo (t1/2 31 (22) versus 115 (67) minutes, p < 0.03). There was little variation in the diameter of the proximal stomach with either LOX or placebo. In the distal stomach marked contractile activity was observed during LOX (ACF 2.9 (0.2) versus 1.5 (2.9) during placebo, p < 0.01). AMP also increased during LOX compared with placebo (56 (22)% versus 27 (16)%, p < 0.001).

Conclusion: The increases in antral motility are likely to contribute to the acceleration of GE and suggest that CCK may regulate GE by acting on the distal stomach although an effect on the proximal stomach cannot be excluded.

PubMed Disclaimer

Figures

Figure 1
Figure 1
: Schematic representation of the experimental design. Every 15 minutes, 30 slices were performed in the transaxial plane to measure gastric emptying, followed immediately by two series of 60 coronal scans (separated by 45 seconds to allow downloading of data) to record gastric motility.
Figure 2
Figure 2
: Technique for gastric motility measurements. In each coronal scan, the gastric image outline by contrast was recalled to the computer monitor and a line projected along the longitudinal axis of the stomach. Two lines perpendicular to this were drawn at fixed distances from the orad margin of the stomach and the length of these lines used to measure proximal and distal gastric diameters.
Figure 3
Figure 3
: Individual half emptying times showing effect of loxiglumide on gastric emptying of 500 ml 10% Intralipid.
Figure 4
Figure 4
: Effect of loxiglumide on the distributions of distal gastric contraction frequency (A) and amplitude (B).

References

    1. Gastroenterology. 1991 Aug;101(2):503-11 - PubMed
    1. Arzneimittelforschung. 1987 Jun;37(6):703-7 - PubMed
    1. Baillieres Clin Gastroenterol. 1991 Jun;5(2):371-407 - PubMed
    1. Gut. 1992 Apr;33(4):466-71 - PubMed
    1. Gastroenterology. 1992 Jul;103(1):114-9 - PubMed

Publication types